Cargando…
Central nervous system aspergillosis in immunocompetent patients: Case series and literature review
The aim of this study was to investigate the clinical characteristics of central nervous system (CNS) aspergillosis in immunocompetent patients. This study enrolled six immunocompetent patients diagnosed with CNS aspergillosis. Additionally, we reviewed the clinical profiles for 28 cases reported in...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598844/ https://www.ncbi.nlm.nih.gov/pubmed/33126348 http://dx.doi.org/10.1097/MD.0000000000022911 |
_version_ | 1783602728917794816 |
---|---|
author | Ma, Yubao Li, Wanjun Ao, Ran Lan, Xiaoyang Li, Yang Zhang, Jiatang Yu, Shengyuan |
author_facet | Ma, Yubao Li, Wanjun Ao, Ran Lan, Xiaoyang Li, Yang Zhang, Jiatang Yu, Shengyuan |
author_sort | Ma, Yubao |
collection | PubMed |
description | The aim of this study was to investigate the clinical characteristics of central nervous system (CNS) aspergillosis in immunocompetent patients. This study enrolled six immunocompetent patients diagnosed with CNS aspergillosis. Additionally, we reviewed the clinical profiles for 28 cases reported in the literature. The age, gender, etiology of Aspergillus infection, clinical manifestations, location of the lesion, treatment, and prognosis were analyzed. There were 19 men (average age, 54.6 ± 14.3 years) and 15 women (average age, 47.0 ± 19.4 years). The clinical manifestations included headache (55.9%; n = 19), visual impairment (32.4%; n = 11), diplopia (32.4%; n = 11), hemiplegia (20.6%; n = 7), fever (17.6%; n = 6), and epilepsy (8.8%; n = 3). According to the radiological features, CNS aspergillosis lesions were divided into two subtypes: parenchymal lesions in the cerebral lobes (n = 11), and meningeal lesions in the meninges (n = 23). The patients with meningeal lesions are easy to be complicated with more serious cerebrovascular diseases, such as subarachnoid hemorrhage and massive infarction. Most of the lesions in brain parenchyma were abscess formation, and magnetic resonance imaging showed ring enhancement. The clinical diagnosis of Aspergillus infection was mainly based on brain biopsy (n = 14), autopsy (n = 8), pathological examination of adjacent brain tissues (n = 7), cerebrospinal fluid (CSF) or tissue culture (n = 3), and second-generation sequencing analysis of the CSF (n = 3). Clinical improvement was achieved in 23 cases, and 11 patients succumbed to the disease. Voriconazole treatment was effective in 24 (70.6%) cases. Immunocompetent subjects are also at risk for Aspergillus infections. Concomitant cerebrovascular diseases are common in patients with CNS aspergillosis, especially in patients with meningeal aspergillosis. Parenchymal aspergillosis lesions are usually localized and manifest as brain abscesses with annular enhancement on magnetic resonance imaging. Biopsy, CSF culture, and next-generation sequencing are mainstream diagnostic modalities. Voriconazole is an effective treatment for Aspergillus infection, and early diagnosis and treatment should be highlighted. |
format | Online Article Text |
id | pubmed-7598844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-75988442020-11-02 Central nervous system aspergillosis in immunocompetent patients: Case series and literature review Ma, Yubao Li, Wanjun Ao, Ran Lan, Xiaoyang Li, Yang Zhang, Jiatang Yu, Shengyuan Medicine (Baltimore) 5300 The aim of this study was to investigate the clinical characteristics of central nervous system (CNS) aspergillosis in immunocompetent patients. This study enrolled six immunocompetent patients diagnosed with CNS aspergillosis. Additionally, we reviewed the clinical profiles for 28 cases reported in the literature. The age, gender, etiology of Aspergillus infection, clinical manifestations, location of the lesion, treatment, and prognosis were analyzed. There were 19 men (average age, 54.6 ± 14.3 years) and 15 women (average age, 47.0 ± 19.4 years). The clinical manifestations included headache (55.9%; n = 19), visual impairment (32.4%; n = 11), diplopia (32.4%; n = 11), hemiplegia (20.6%; n = 7), fever (17.6%; n = 6), and epilepsy (8.8%; n = 3). According to the radiological features, CNS aspergillosis lesions were divided into two subtypes: parenchymal lesions in the cerebral lobes (n = 11), and meningeal lesions in the meninges (n = 23). The patients with meningeal lesions are easy to be complicated with more serious cerebrovascular diseases, such as subarachnoid hemorrhage and massive infarction. Most of the lesions in brain parenchyma were abscess formation, and magnetic resonance imaging showed ring enhancement. The clinical diagnosis of Aspergillus infection was mainly based on brain biopsy (n = 14), autopsy (n = 8), pathological examination of adjacent brain tissues (n = 7), cerebrospinal fluid (CSF) or tissue culture (n = 3), and second-generation sequencing analysis of the CSF (n = 3). Clinical improvement was achieved in 23 cases, and 11 patients succumbed to the disease. Voriconazole treatment was effective in 24 (70.6%) cases. Immunocompetent subjects are also at risk for Aspergillus infections. Concomitant cerebrovascular diseases are common in patients with CNS aspergillosis, especially in patients with meningeal aspergillosis. Parenchymal aspergillosis lesions are usually localized and manifest as brain abscesses with annular enhancement on magnetic resonance imaging. Biopsy, CSF culture, and next-generation sequencing are mainstream diagnostic modalities. Voriconazole is an effective treatment for Aspergillus infection, and early diagnosis and treatment should be highlighted. Lippincott Williams & Wilkins 2020-10-30 /pmc/articles/PMC7598844/ /pubmed/33126348 http://dx.doi.org/10.1097/MD.0000000000022911 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 5300 Ma, Yubao Li, Wanjun Ao, Ran Lan, Xiaoyang Li, Yang Zhang, Jiatang Yu, Shengyuan Central nervous system aspergillosis in immunocompetent patients: Case series and literature review |
title | Central nervous system aspergillosis in immunocompetent patients: Case series and literature review |
title_full | Central nervous system aspergillosis in immunocompetent patients: Case series and literature review |
title_fullStr | Central nervous system aspergillosis in immunocompetent patients: Case series and literature review |
title_full_unstemmed | Central nervous system aspergillosis in immunocompetent patients: Case series and literature review |
title_short | Central nervous system aspergillosis in immunocompetent patients: Case series and literature review |
title_sort | central nervous system aspergillosis in immunocompetent patients: case series and literature review |
topic | 5300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598844/ https://www.ncbi.nlm.nih.gov/pubmed/33126348 http://dx.doi.org/10.1097/MD.0000000000022911 |
work_keys_str_mv | AT mayubao centralnervoussystemaspergillosisinimmunocompetentpatientscaseseriesandliteraturereview AT liwanjun centralnervoussystemaspergillosisinimmunocompetentpatientscaseseriesandliteraturereview AT aoran centralnervoussystemaspergillosisinimmunocompetentpatientscaseseriesandliteraturereview AT lanxiaoyang centralnervoussystemaspergillosisinimmunocompetentpatientscaseseriesandliteraturereview AT liyang centralnervoussystemaspergillosisinimmunocompetentpatientscaseseriesandliteraturereview AT zhangjiatang centralnervoussystemaspergillosisinimmunocompetentpatientscaseseriesandliteraturereview AT yushengyuan centralnervoussystemaspergillosisinimmunocompetentpatientscaseseriesandliteraturereview |